newest glp-1 drugs List of approved and pending medications The GLP-1 Revolution: From Diabetes
Description
In a separate analysis, lixisenatide reduced incident macroalbuminuria, while adjustments for baseline characteristics such as age, blood pressure and eGFR, as well as on trial HbA1c, blood pressure and weight, did not significantly attenuate the association [28]
doi: 10.1007/s00404-024-07849-9 [DOI] [PMC free article] [PubMed] [Google Scholar] 227.Willard FS, Douros JD, Gabe MB, et al
They are distinguished by their consistent T cell receptor (TCR) that detects lipid-based antigens presented by CD1d glycoproteins
doi: 10.1111/j.1463-1326.2008.01018.x [DOI] [PubMed] [Google Scholar] 36.AstraZeneca Pharmaceuticals LP
Drucker DJ, Buse JB, Taylor K, Kendall DM, Trautmann M, Zhuang D, et al
